Trial Profile
Asociation between atazanavir (ATV) levels and other related toxicities along with clinical covariates affecting the atazanavir concentrations in HIV-infected patients.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Dec 2015
Price :
$35
*
At a glance
- Drugs Atazanavir (Primary)
- Indications HIV infections
- Focus Adverse reactions; Pharmacokinetics
- 14 Dec 2015 New trial record